EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases

Bożena Bukowska iD

International Journal of Molecular Sciences · 27.11.2024 · 25 (23) · 12738

DOI: 10.3390/ijms252312738 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.11.2024. Verfasst von Bożena Bukowska. Beteiligte Einrichtung: Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska Street141/143, 90-…. Hauptthemen laut MEDLINE: Cannabis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Lodz, Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis sativa L. contains numerous compounds with antioxidant and anti-inflammatory properties, including the flavonoids and the cannabinoids, particularly Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Cannabinoids have an effect on the endocannabinoid system (ECS), a cellular communication network, and are, hence, widely studied for medical applications. Epidiolex®, a 99% pure oral CBD extract, has been approved by the FDA for the treatment of epilepsy. Nabiximols (Sativex) is an oromucosal spray containing equal volume of THC and CBD, and it is commonly used as an add-on treatment for unresponsive spasticity in multiple sclerosis (MS) patients. Several in vitro and in vivo studies have also shown that cannabinoids can be used to treat various types of cancer, such as melanoma and brain glioblastoma; the first positive clinical trials on the anticancer effect of a THC:CBD blend with temozolomide (TMZ) in the treatment of highly invasive brain cancer are very promising. The cannabinoids exert their anticancer properties in in vitro investigations by the induction of cell death, mainly by apoptosis and cytotoxic autophagy, and the inhibition of cell proliferation. In several studies, cannabinoids have been found to induce tumor regression and inhibit angiogenic mechanisms in vitro and in vivo, as well as in two low-numbered epidemiological studies. They also exhibit antiviral effects by inhibiting ACE2 transcription, blocking viral replication and fusion, and acting as anti-inflammatory agents; indeed, prior CBD consumption (a study of 93,565 persons in Chicago) has also been associated with a much lower incidence of SARS-CoV-2 infections. It is postulated that cannabis extracts can be used in the treatment of many other diseases such as systemic lupus erythematosus, type 1 diabetes, or various types of neurological disorders, e.g., Alzheimer’s disease. The aim of this review is to outline the current state of knowledge regarding currently used medicinal preparations derived from C. sativa L. in the treatment of selected cancer and viral diseases, and to present the latest research on the potential applications of its secondary metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisHumansCannabinoidsNeoplasmsAnimalsPlant ExtractsCOVID-19 Drug TreatmentCOVID-19CannabidiolSARS-CoV-2

Stichwörter der Autor:innen

anti-inflammatory propertiesanticancer propertiesantioxidant effectsantiviral effectscannabidiolcannabinoidstetrahydrocannabinol

Substanzen

CannabinoidsPlant ExtractsCannabidiol

Autor:innen und Institutionen

  • Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska Street141/143, 90-236 Lodz, Poland.

ORCID-Profile: Bożena Bukowska

Förderung

  • University of Lodz
  • Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz

Zitieren

APA

Bukowska, B. (2024). Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases. International Journal of Molecular Sciences, 25(23), 12738. https://doi.org/10.3390/ijms252312738

Vancouver

Bukowska B. Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases. International Journal of Molecular Sciences. 2024;25(23):12738. doi:10.3390/ijms252312738

BibTeX
@article{Bukowska2024,
  author = {Bukowska, Bożena},
  title = {Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {23},
  pages = {12738},
  doi = {10.3390/ijms252312738}
}
Kostenlos starten →